These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28092947)

  • 1. Pyrrolizidine Alkaloids: Metabolic Activation Pathways Leading to Liver Tumor Initiation.
    Fu PP
    Chem Res Toxicol; 2017 Jan; 30(1):81-93. PubMed ID: 28092947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrrolizidine Alkaloid Secondary Pyrrolic Metabolites Construct Multiple Activation Pathways Leading to DNA Adduct Formation and Potential Liver Tumor Initiation.
    Xia Q; He X; Ma L; Chen S; Fu PP
    Chem Res Toxicol; 2018 Jul; 31(7):619-628. PubMed ID: 29855181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic formation of DHP-derived DNA adducts from a representative otonecine type pyrrolizidine alkaloid clivorine and the extract of Ligularia hodgsonnii hook.
    Xia Q; Chou MW; Lin G; Fu PP
    Chem Res Toxicol; 2004 May; 17(5):702-8. PubMed ID: 15144228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity and tumorigenicity induced by metabolic activation of pyrrolizidine alkaloids in herbs.
    Li N; Xia Q; Ruan J; Fu PP; Lin G
    Curr Drug Metab; 2011 Nov; 12(9):823-34. PubMed ID: 21619520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrrolizidine alkaloid-derived DNA adducts are common toxicological biomarkers of pyrrolizidine alkaloid N-oxides.
    He X; Xia Q; Woodling K; Lin G; Fu PP
    J Food Drug Anal; 2017 Oct; 25(4):984-991. PubMed ID: 28987376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.
    Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G
    Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-Glutathione-pyrrole and 7-cysteine-pyrrole are potential carcinogenic metabolites of pyrrolizidine alkaloids.
    He X; Xia Q; Fu PP
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2017 Apr; 35(2):69-83. PubMed ID: 28418776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids.
    Yang M; Ma J; Ruan J; Ye Y; Fu PP; Lin G
    Arch Toxicol; 2019 Aug; 93(8):2197-2209. PubMed ID: 31222523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and secondary pyrrolic metabolites of pyrrolizidine alkaloids form DNA adducts in human A549 cells.
    He X; Xia Q; Wu Q; Tolleson WH; Lin G; Fu PP
    Toxicol In Vitro; 2019 Feb; 54():286-294. PubMed ID: 30366057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrrole-protein adducts - A biomarker of pyrrolizidine alkaloid-induced hepatotoxicity.
    Ma J; Xia Q; Fu PP; Lin G
    J Food Drug Anal; 2018 Jul; 26(3):965-972. PubMed ID: 29976414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo.
    Wang YP; Fu PP; Chou MW
    Int J Environ Res Public Health; 2005 Apr; 2(1):74-9. PubMed ID: 16705803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo.
    Yang YC; Yan J; Doerge DR; Chan PC; Fu PP; Chou MW
    Chem Res Toxicol; 2001 Jan; 14(1):101-9. PubMed ID: 11170513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Formyl-7-hydroxy-6,7-dihydro-5 H-pyrrolizine (1-CHO-DHP): A Potential Proximate Carcinogenic Metabolite of Pyrrolizidine Alkaloids.
    He X; Xia Q; Gamboa da Costa G; Lin G; Fu PP
    Chem Res Toxicol; 2019 Jun; 32(6):1193-1203. PubMed ID: 31120748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine.
    Xia Q; Chou MW; Edgar JA; Doerge DR; Fu PP
    Cancer Lett; 2006 Jan; 231(1):138-45. PubMed ID: 16356839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine.
    Chou MW; Wang YP; Yan J; Yang YC; Beger RD; Williams LD; Doerge DR; Fu PP
    Toxicol Lett; 2003 Dec; 145(3):239-47. PubMed ID: 14580895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts.
    Ma J; Li M; Li N; Chan WY; Lin G
    Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34679016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity.
    Xia Q; Zhao Y; Von Tungeln LS; Doerge DR; Lin G; Cai L; Fu PP
    Chem Res Toxicol; 2013 Sep; 26(9):1384-96. PubMed ID: 23937665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J; Xia Q; Chou MW; Fu PP
    Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoirradiation of dehydropyrrolizidine alkaloids--formation of reactive oxygen species and induction of lipid peroxidation.
    Zhao Y; Xia Q; Yin JJ; Lin G; Fu PP
    Toxicol Lett; 2011 Sep; 205(3):302-9. PubMed ID: 21723383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.
    Yang M; Ruan J; Fu PP; Lin G
    Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.